Preterm labor and preterm premature rupture of the membranes. Diagnosis and management.
Preterm delivery due to preterm labor and pPROM is responsible for most infant morbidity and mortality in the United States. The patient who presents with suspicious symptoms should undergo a thorough evaluation to confirm the diagnosis of either entity and identify a treatable cause. Determination of gestational age, fetal well-being, and the presence of intrauterine infection is a crucial step in subsequent management. Corticosteroid therapy has been demonstrated to be one of the most effective antenatal interventions to reduce infant morbidity and should be administered to patients with preterm labor, if feasible, when fetal pulmonary maturity is absent or undocumented. We recommend a similar protocol regarding gravidas with pPROM remote from term but recognize the need for further study in this area. Acute tocolytic therapy has been demonstrated to offer short-term benefit to enhance corticosteroid effect. However, all of the available tocolytic agents carry significant risks to the mother and fetus. As such, administration of these agents should be given only when the potential benefits outweigh the risks of administration. Evaluation for fetal pulmonary maturity and intrauterine infection, in concert with evaluation of gestational age-dependent risks of prematurity, may be helpful in determining whether tocolysis should be attempted. Adjunctive antibiotic administration has not been shown to reduce maternal or infant morbidity in the face of preterm labor. However, such treatment offers a reduction of chorioamnionitis, prolongation of latency, and a possible reduction of neonatal infectious and gestational age-dependent morbidity in the setting of pPROM remote from term. Finally, current guidelines recommend the administration of intrapartum GBS prophylaxis when preterm birth or prolonged membrane rupture is anticipated if GBS carrier status is unknown or positive. Intrapartum treatment with intravenous penicillin or ampicillin is appropriate.
Mercer
B M
BM
Department of Obstetrics and Gynecology, University of Tennessee, Memphis Health Sciences Center, USA.
Lewis
R
R
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis; D002821:Chorioamnionitis / Q000175:diagnosis; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000175:diagnosis* / Q000628:therapy; D005353:Fibronectins / Q000032:analysis; D006801:Humans; D007752:Obstetric Labor, Premature / Q000175:diagnosis* / Q000628:therapy; D010808:Physical Examination; D011247:Pregnancy; D015145:Tocolysis
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D005353:Fibronectins